Christian Torp-Pedersen

Author PubWeight™ 8.61^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.	J Am Coll Cardiol	2014	3.75
2	Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.	Eur J Heart Fail	2016	2.03
3	Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.	BMJ	2015	1.41
4	Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.	PLoS One	2016	0.89
5	Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.	Eur Heart J	2017	0.83
6	Cardiopulmonary Resuscitation Training in Schools Following 8 Years of Mandating Legislation in Denmark: A Nationwide Survey.	J Am Heart Assoc	2017	0.78
7	Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.	Eur Heart J Cardiovasc Pharmacother	2016	0.78
8	Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.	Eur Heart J	2016	0.76
9	Associations between metabolic disorders and risk of cancer in Danish men and women - a nationwide cohort study.	BMC Cancer	2016	0.76
10	Home Care Providers to the Rescue: A Novel First-Responder Programme.	PLoS One	2015	0.75
11	Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.	Heart	2016	0.75